Set to ship 8 million coronavirus vaccine doses on Monday, US govt says

The chief science adviser for the US government's vaccine distribution effort says it will be shipping nearly 8 million doses of coronavirus vaccine on Monday

Topics
Coronavirus Vaccine | Coronavirus | US government

AP  |  Washington 

Coronavirus, vaccine, covid, drugs, clinical trials
Representative photo of a vaccine

The chief science adviser for the US government's vaccine distribution effort says it will be shipping nearly 8 million doses of vaccine Monday.

Dr. Moncef Slaoui said Sunday on CNN's State of the Union that 5.9 million doses of a vaccine made by Moderna and 2 million of a vaccine made by Pfizer will be shipped.

At least a dozen states reported last week that they would receive a smaller second shipment of the Pfizer vaccine than they had been told previously.

Army Gen. Gustave Perna, in charge of the distribution effort, apologized Saturday for miscommunication with states over the number of doses to be delivered in the early stages of distribution.

Slaoui said the mistake was assuming vaccines that had been produced were ready for shipment when there was a two-day delay.

And unless it's perfectly right, we will not release vaccine doses for usage, he said. And, sometimes, there could be small hiccups. There have been none, actually, in manufacturing now. The hiccup was more into the planning. Slaoui also said the U.S. will experience a continuing surge in the coronavirus, with larger numbers of cases possible from gatherings for the Christmas holiday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Mon, December 21 2020. 06:58 IST
RECOMMENDED FOR YOU